SEC Form 4 · accession 0001193125-26-359189
Rapport Therapeutics, Inc. · RAPP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Krishnaswamy Yeleswaram
Officer — Chief Development Officer
Period of report
Aug 19, 2026
Accepted (ET)
Aug 20, 2026 · 4:09 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0002012593
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 19, 2026 | S | 404 | $49.90 | D | 246,022 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.